The Asia Pacific is the fastest-growing region for the insulin market owing to the increasing prevalence of diabetes in India and China's country is propelling the growth of the insulin market. Approximately, 114 million in China and 72 million in India suffered from diabetes. Furthermore, the increasing prevalence of Type 2 is supporting the growth of the insulin market in the future. Type 2 diabetes accounts for 90-95 % of the total diabetes population is supporting the growth of the market. - http://bit.ly/2mVN7Mr






